OPKO Health (OPK) continues to gain traction from solid prospects in RAYALDEE and BioReference platforms.
OPKO Health (OPK) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
MIAMI, May 27, 2020 -- OPKO Health, Inc. (NASDAQ:  OPK) announced today that management will be participating in the Jefferies Virtual Healthcare Conference being held June.

96 Biggest Movers From Yesterday

08:20am, Wednesday, 27'th May 2020
The company has been able to rapidly ramp up testing for COVID-19. Its revenue figures are down as sales of its other products have been affected by confinement
Israel stocks higher at close of trade; TA 35 up 0.77%
Israel stocks higher at close of trade; TA 35 up 1.30%
OPKO Health (OPK) is seeing positive earnings estimate revisions, suggesting that it could be a solid choice for investors
Stocks Analysis by Zacks Investment Research covering: . Read Zacks Investment Research's latest article on Investing.com

Moving Average Crossover Alert: OPKO Health

12:30pm, Tuesday, 19'th May 2020
OPKO Health, Inc. (OPK) is looking like an interesting pick from a technical perspective, as the company is seeing favorable trends on the moving average crossover front.
OPKO Health's (OPK) subsidiary, BioReference Laboratories collaborates with MagnaCare to offer antibody testing to Labor groups in New York metropolitan area.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE